3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
6
Thyroid Nodule
1
Pancreatic Cystic Neoplasm
1
Malignant Non-small Cell Neoplasm of Lung Stage Ia
1
Malignant Liver Neoplasm
1
Liver Neoplasms
1
Liver Diseases
1
Kidney Neoplasms
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Biliary Tract Neoplasms
1
Interventions
Sorafenib
5
lenvatinib
2
ledipasvir, sofosbuvir drug combination
2
halofantrine
2
atezolizumab
2
Liver Transplantation
2
Immunotherapy
2
Control Groups
2
Blood Specimen Collection
2
Bevacizumab
2
Antibodies
2
veliparib
1
trifluridine tipiracil drug combination
1
trametinib
1
titanium silicide
1
sintilimab
1
rubitecan
1
repotrectinib
1
pevonedistat
1
pembrolizumab
1
ozanimod
1
linifanib
1
genexol-PM
1
fluorocholine
1
fisogatinib
1
ficlatuzumab
1
durvalumab
1
camrelizumab
1
belinostat
1
bavituximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Liver Diseases
×
Catheter Ablation
×
Clear all
NCT04727307
2025-09-30
AB-LATE02
University Hospital, Montpellier
Phase 2
Recruiting
202 enrolled